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Abstract
Given the high and rising figures of people with osteoarthritis, knowledge of new 
factors defining course and evolution of the disease are important, when consider-
ing new pharmacological targets. IL-1 is a very important cytokine in the early steps 
of osteoarthritis, giving the high sensitivity of the chondrocytes to this cytokine, 
and it can be considered the bridge permiting the dialogue between the different 
structures of the articulation, in such a way that the cartilage is not the only tissue 
affected in OA. IL-1 increases the destruction of the extracellular matrix of the carti-
lage increasing the collagenolytic activity of metalloproteases, increasing activity of 
nytric oxide ON, wich can induce apoptosis of chondrocytes. Interestingly, IL-1 further 
induces changes in the homeostasis of the cartilage, lessening activity of growth 
factors, such as TGF-beta.
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Osteoarthritis impact and magnitude
Osteoarthritis (OA) is the most common joint disease and it 
is ranked among the most frequent and symptomatic caus-
ing health-problems disease for middle-aged people as well 
as in the elderly. The main characteristic of OA is an imbalance 
between chondrocyte anabolic and catabolic activities, as it is 
described in the section of cartilage homeostasis. 
 
The implications of this burden are poor quality of life, restric-
tions in daily activities and progressive disability (van der Waal 
JM et al, 2005). 
 
The biggest condition causing disability is osteoarthritis, and 
altogether with joint pain in older people—will be an increas-
ingly important public health concern in the elderly.
Osteoarthritis pathophysiology
 
Degenerative articular disease is best characterized by a lost of 
the equilibrium or changes in the cartilage homeostasis, and 
it means further degradation of the molecules of the cartilage 
matrix. 
 
The lost of proteoglycans and another macromolecules from 
cartilage yields in a progresive tisular destruction, causing de-
terioration of the smooth cartilage surface (Pujol JP, 1998).
 
Synovitis in osteoarthritis
Synovial inflamation occurs early in OA and can be subclinical, 
as arthroscopic studies suggest that localized proliferative and 
inflammatory changes of the synovium occur in up to 50% 
of OA patients (many of whom do not appear to have active 
inflammation) (Krasnokutsky S et al, 2007). 
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Extracellular matrix
of the cartilage.
The extracellular matrix represents 
the microenvironment for the chon-
drocytes, in addition to its mechani-
cal importance. 
 
Loss of cartilage homeostasis
During joint disease, the normal 
equilibrium in cartilage is disrupted 
and the rate of loss of collagens and 
proteoglycans from the matrix clearly 
exceed the rate of deposition of newly 
synthesized molecules, resulting in 
cartilage damage (Goldring MB & 
Marcu KB, 2009)
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The synovium produces some of the chemokines and 
metalloproteinases that degrade cartilage, even though the 
chondrocytes produces mostly of these destructive molecules. 
This picture is attributted to the presence of IL-1 in the 
synoviocites. 
Synovitis plays a stablished role in the progression of osteo-
arthritis and the overproduction of cytokines specially inter-
leukin 1 and growth factors from the inflamed synovium can 
influence the production of degradative enzymes such as 
matrix metalloproteases causing the destruction of cartilage 
(Bondeson J et al, 2006)
 
Chondrocyte role in cartilage 
maintenance
The chondrocytes are the only cell type found in cartilage 
and it regulates the maintenance of the cartilage extracellular 
matrix. 
cartilage are responsible for the homeostasis of this tissue. In 
normal conditions, each chondrocyte interacts with this peri-
cellular matrix in order to keep their cellular phenotype stable. 
In that way chondrocytes are responsible for maintaining in a 
low-turnover state the unique composition and organization 
of the matrix. 
A big deal of research in vitro and in vivo  in the past two de-
cades confirmed that chondrocytes in hyaline cartilage re-
spond to mechanical injury, joint instability due to genetic 
factors, and biological stimuli such as cytokines and growth 
and differentiation factors. These molecules contribute to 
structural changes in the surrounding cartilage matrix (Gold-
ring MB & Marcu KB, 2009)
 
Cartilage homeostasis is the result of an equilibrated produc-
tion and destruction of the ECM, but in osteoarthritis destruc-
tion predominates beacause of an excessive production of IL-1 
induced metalloproteases, going simultaneously with IL-1 in-
duced alteration of the local growing factors such as TGF-beta 
(Pujol JP, 1998). 
 
Description of IL-1
Interleukin (IL)-1 is a cytokine that plays a major role in inflam-
matory responses in the context of infections and immune-
mediated diseases. 
 
IL-1 is a very low molecular weight soluble peptide of the family 
of glycoproteins, produced and secreted in an inactive form, 
called proIL-1. Il-1 acts in very small quantities in the order of 
picomoles, suggesting there exist an in situ mechanism act-
ing whether in a paracrine or in an autocrine way. Il-1 has no 
enzimatic activity (Mathieu P, 1999).
 
IL-1 refers to two different cytokines, termed IL-1alpha and IL-
1beta, and they are produced from the activity of two genes. 
(Jacques C et al, 2006)
Hematoxillin and eosin dye of hyaline cartilage 
Head arrows shows chondrocytes.
Chondrocyte. 
The maintenance of articular cartilage integrity requires a deli-
cate balance between anabolic process (synthesis) and ana-
bolic process (degradation). In this delicate balance it is well 
known that cytokin IL-1 increases the degradation of proteo-
glycans and collagens. 
 
Cartilage homeostasis
The adult articular cartilage shows a slow tissue turnover. In 
this turnover, new optimal tissue bearing biomechanical stress 
is built and defective tissue is removed. Thus, one of the most 
important issues in osteoarthritis research is to understand the 
adequate homeostasis of catabolic and anabolic factors in ar-
ticular cartilage (Aigner T et al, 2006).
Whereas the matrix is the functional component of the articu-
lar cartilage, the chondrocytes as the cell population of the 
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IL-1 production
It is considered three structures producing IL-1 in the articula-
tion and triggering destruction in OA. Such an structures are, 
according to Mathieu (1999):
•  The synovial membrane. The synthesis of IL-1 is triggered by 
the resorption of debris cartilage appearing in the articular 
cavity when there is defragmentation of proteoglycans ag-
gregates. IL-1 present in the synovial fluid penetrates trough-
out the fissures of fibrilation in cartilage and then reaches the 
deep layers of the cartilage.
•  The bone from areas directly in contact with the calcified 
cartilage.
•  The cartilage because of the mechanical stimulation of chon-
drocytes.
 
 
Levels of IL-1 in OA patients
It has been quantificated by ELISA method, employing murine 
antibodies to bind directly to IL-1 and rabbit antibodies marked 
with alkaline phosphatase to bind to the murine antibodies; 
the levels of Il-1 in OA, were 2,47 pg/mL at day 0, and with 
administration of diacerhein 100 mg daily the levels down up 
to 0,28 pg/mL at day 28 (Mathieu 1999). 
Nevertheles this figures, there is controversy to correlate high 
levels with development of OA because there is high sensitivity 
of the chondrocytes to IL-1 and is known that OA chondrocytes 
are x4 times more sensitive to deleterious effects of IL-1 when 
compared to normal chondrocytes.
 
 
IL-1 and its role in the pathophysiology  
of osteoarthrtitis
IL-1 stimulates the synthesis and activity of matrix metallopro-
teinases and other enzymes involved in cartilage destruction 
in rheumatoid arthritis and osteoarthritis.
 
Cytokines produced by the synovium and chondrocytes, espe-
cially interleukin IL-1 and tumor necrosis factor alpha (TNF-α) 
), play a significant role in the degradation of cartilage (De Isla 
& Stoltz JF, 2008)
 
The initial stages of cartilage damage are characterized by a 
loosening of the collagen network and a loss of proteoglycans 
starting in the superficial and upper middle zones. This dam-
age spreads to deeper cartilage layers as the OA joint degen-
eration is going on. This type of damage is at least potentially 
reversible, due to the possibility of an effective increasing in 
the turnover of the proteoglycans in the adult tissue (Aigner 
T et al, 2006).
 
IL-1 is a potent pro-inflammatory cytokine capable of inducing 
chondrocytes and synovial cells to synthesize MMPs. Further-
more, IL-1 suppresses the synthesis of type II collagen and pro-
teoglycans, and inhibits transforming growth factor-ß stimu-
lated chondrocyte proliferation. Further the presence of IL-1 
RNA and protein have been confirmed in OA joints.
 
Interleukin-1 beta (IL-1F2) was detected in inmersion fixed 
LPS-stimulated rat splenocytes using rat IL-1 beta antigen-
purified policlonal antibody at 5 mcg/mL for 3 hours at 
room temperature
Interleukin-1 alpha (IL-1F1) was detected in inmersion fixed 
monensin human peripheral blood mononuclear cells 
(PBMCs), using human IL-1 alpha monoclonal antibodies at 
10 mcg/ml for 3 hours at room temperature.
Links for images: IL-1 beta
http://www.rndsystems.com/ihc_molecule_images.
aspx?m=1629
IL-1 alpha
http://www.rndsystems.com/ihc_molecule_images.
aspx?m=1628
Images by kind courtesy of Tim Manning. http://www.rndsystems.com
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IL-1 further diminishes expression in the cartilage matrix of 
the type II and IX collagens (Pujol JP 1998). IL-1 beta has been 
shown to be predominantly involved in the pathophysiology 
and progression of osteoarthritis.
 
 
IL-1 and its effects in chondrocyte
  
Nitric oxide (NO) is a pleiotropic mediator that has been shown 
to be intimately involved in the OA and its inhibition can in-
duce a significant reduction in the progression of structural 
changes of the disease. 
In another hand, OA chondrocytes have been shown to ex-
press iNOS the enzume sintetizing ON and consequently to 
produce large amounts of NO, especially upon stimulation by 
proinflammatory cytokines (Boileau C et al, 2002) 
 
Therefore, the oxidant molecule nitric oxide plays multiple 
roles with respect to chondrocytes because it promotes carti-
lage degradation, including inhibition of collagen and proteo-
glycan synthesis, it activates MMP and increased susceptibility 
to other oxidant injury. nitric oxide further induces oxidative 
injury int he chondrocyte resulting in premature senescence 
and apoptosis (Krasnokutsky S et al, 2007)
 
Growth factors
Growth factors such as transforming growth factor beta stim-
ulate collagens and proteoglycans synthesis by chondrocyte, 
and reduce the activity of IL-1β stimulated metalloproteases. 
By its capability to reduce IL-1 effects and to stimulate TGF-β 
expression in cultured articular chondrocytes, drugs such as 
diacerein could elicitate the anabolic processes in the OA car-
tilage, contributing to delay the progression of the disease, and 
supporting structure modification in osteoarthritis (DMOAD) 
(De Isla NG & Stoltz JF 2008).
 
Metalloproteases
In OA, synthesis of the enzymes called metalloproteases 
(MMPs) is greatly enhanced and the available inhibitors (tissue 
inhibitors of MMP or TIMPs) are overwhelmed, resulting in net 
degradation of cartilage. 
In OA, these degradative enzymes are produced primarily by 
chondrocytes due to inductive stimuli, including a wide variety 
of stimules such as mechanical stress, injury with destabiliza-
tion,  cell-matrix interactions, oxidative stress,and changes in 
growth factor responses (such as TGF-β) during the aging pro-
cess (Goldring MB & Marcu KB, 2009).
 
Ways to demonstrate IL-1 is elevated in 
OA
There is recent research with imaging techniques of magnetic 
resonance in which significant correlation between  IL-1β  (r = 
0.48, P < 0.05) and fractional anisotropy of the magnetic reso-
nance and inverse correlations between planar anisotropy of 
the magnetic resonance and IL-1β and soluble intercelular ad-
hesion molecule (sICAM) (r = 0.48, P < 0.05 and r = 0.49, P < 0.05, 
respectively) were observed (Aggarwal V et al, 2009).
Mathieu (1999) describe ELISA in synovial fluid of knee OA pa-
tients, with range between 2,47 and 0,28 pg/mL. 
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¿Why is IL-1 important in the pathogenesis of 
osteoarthritis?
Because chondrocyte is very sensitive to the effects of IL-1. 
Barely 1% of the receptors of IL-1 occupied in the surface of 
the cartilage, changes the fenotype of the chondrocyte to a 
catabolic one. Further the osteoarthritic chondrocyte is 3-4 
times more sensitive to the effects of IL-1 (Mathieu P, 1999) 
 
ICE enzyme and IL-1 beta production
IL-1 gives origin to an active moiety of IL-1 through the action of 
Interleukin 1 converting enzyme or ICE. This enzyme produce 
active, mature IL-1beta. 
 
The level of ICE has been demonstrated to be increased in OA 
tissues and according to investigative work of Boileau et al, it 
has been found to increase the production of active IL-1beta as 
well as IL-18. ICE is a crucial enzyme in the activation process of 
IL-1beta and IL-18, two important pro-inflammatory cytokines 
involved in the progression of OA. (Boileau C et al, 2002)
 
Nitric oxide and IL-1
The production of nitric oxide (NO), which is stimulated by pro-
inflammatory cytokines, is involved in cartilage catabolism and 
also may induce the apoptosis of chondrocytes. The NO pro-
duced by iNOS in activated chondrocytes in diseased cartilage 
may modulate disease progression in OA (Studer RK et al, 1999)
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Pharmacological Inhibition of IL-1: use-
fulness as treatment in OA
Drugs such as diacerein could inhibit catabolic responses like 
NO synthesis as well as MMP activity but it could also increase 
anabolic responses like collagen type II synthesis. 
Furthermore, diacerein can inhibit the binding of NF-κB and 
AP-1 transcription factors, two key factors involved in the ex-
pression of several pro-inflammatory genes by chondrocytes, 
such as the inducible nitric oxide synthase gene, supporting 
the anti-osteoarthritic effects. (De Isla NG & Stoltz JF 2008). 
 
 
Conclusions
IL-1 is a glycoprotein of very low molecular weight, acting in 
paracrine or autocrine pathways in the sensitive cells. Chon-
drocytes are very sensitive to the actions of IL-1 because with 
barely 1% of the receptors occupied in the surface, it turns into 
catabolic fenotype.
IL-1 induces synthesis of matrix metalloproteases which are 
the main enzymes implicated in destruction of the ECM com-
ponents. Further it induces the synthesis of ON, implicated in 
aging and apoptosis of chondrocytes.
Homeostasis of the cartilage depends on the equilbrium be-
tween destruction and synthesis of the components of ECM, 
and when IL-1 levels are superior to normal, grow factors such 
as TGF-beta are affected, halting the anabolic fenotype of the 
chondrocyte.
Although determination of IL-1 is not easy because it is pres-
ent at picomolar levels, some surrogates are being progresively 
available, such as imaging techniques with magnetic reso-
nance.
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“A live version of this article can be found on the net at: http://knol.google.com/k/il-1-and-its-role-in-osteoarthritis”
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